Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 128.00 | |
25 mg | In stock | $ 249.00 | |
50 mg | In stock | $ 452.00 | |
100 mg | In stock | $ 665.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 79.00 |
Description | JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4). |
Synonyms | CGI-1842, JI 101 |
Molecular Weight | 466.33 |
Formula | C22H20BrN5O2 |
CAS No. | 900573-88-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (58.97 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JI-101 900573-88-8 Angiogenesis Tyrosine Kinase/Adaptors VEGFR PDGFR Ephrin Receptor Inhibitor Vascular endothelial growth factor receptor CGI1842 CGI-1842 JI 101 Platelet-derived growth factor receptor JI101 CGI 1842 inhibit inhibitor